Tiger's Take
In my view, the Tecomet-Orchid merger is the definitive signal that the "supply chain as a service" model has reached its endgame in the orthopedic sector.
By creating a manufacturing titan, the industry effectively shifts from a fragmented vendor landscape to a consolidated, dual-pillar structure where a single partner can manage a product's entire lifecycle—from raw forging to sterile packaging.
While this offers the "Big Ortho" the streamlined, resilient partnership they’ve craved since the 2020 disruptions, it creates a formidable barrier for Small Ortho, the real innovator...
